Crisis-driven innovation in the Republic of Korea's in vitro diagnostics industry: a pandemic case study

This study provides a strategic framework for understanding interactions between pandemic control policies and the IVD industry. Sustained pre-crisis investment in R&D, public-private networks, and public health infrastructure is essential for effective pandemic preparedness. During a crisis, policymakers must carefully manage the critical trade-off between regulatory speed and diagnostic quality to ensure that rapid responses do not compromise public health outcomes.